Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 70


Elevated Circulating Interleukin 33 Levels in Stable Renal Transplant Recipients at High Risk for Cardiovascular Events.

Mansell H, Soliman M, Elmoselhi H, Shoker A.

PLoS One. 2015 Nov 6;10(11):e0142141. doi: 10.1371/journal.pone.0142141. eCollection 2015.


Socio-Economic Factors, Food Habits and Phosphorus Levels in Patients on Hemodialysis.

Santoro D, Ingegnieri MT, Vita G, Lucisano S, Zuppardo C, Canale V, Savica V, Buemi M.

Nephrourol Mon. 2015 Jul 30;7(4):e27114. doi: 10.5812/numonthly.27114. eCollection 2015 Jul.


Hyperphosphatemia Is an Independent Risk Factor for Mortality in Critically Ill Patients: Results from a Cross-Sectional Study.

Haider DG, Lindner G, Wolzt M, Ahmad SS, Sauter T, Leichtle AB, Fiedler GM, Fuhrmann V, Exadaktylos AK.

PLoS One. 2015 Aug 7;10(8):e0133426. doi: 10.1371/journal.pone.0133426. eCollection 2015.


The Envy of Scholars: Applying the Lessons of the Framingham Heart Study to the Prevention of Chronic Kidney Disease.

Wasser WG, Gil A, Skorecki KL.

Rambam Maimonides Med J. 2015 Jul 30;6(3). doi: 10.5041/RMMJ.10214.


Dysregulation of phosphate metabolism and conditions associated with phosphate toxicity.

Brown RB, Razzaque MS.

Bonekey Rep. 2015 Jun 3;4:705. doi: 10.1038/bonekey.2015.74. eCollection 2015. Review.


Hyperphosphate-Induced Myocardial Hypertrophy through the GATA-4/NFAT-3 Signaling Pathway Is Attenuated by ERK Inhibitor Treatment.

Liu YL, Huang CC, Chang CC, Chou CY, Lin SY, Wang IK, Hsieh DJ, Jong GP, Huang CY, Wang CM.

Cardiorenal Med. 2015 Apr;5(2):79-88. doi: 10.1159/000371454. Epub 2015 Jan 27.


Hyperphosphatemia. The hidden killer in chronic kidney disease.

Askar AM.

Saudi Med J. 2015 Jan;36(1):13-9. doi: 10.15537/smj.2015.1.9843.


Cholesterol-cholate-butterfat diet offers multi-organ dysfunction in rats.

Jamshed H, Arslan J, Gilani AU.

Lipids Health Dis. 2014 Dec 16;13:194. doi: 10.1186/1476-511X-13-194.


Severe vascular calcification and tumoral calcinosis in a family with hyperphosphatemia: a fibroblast growth factor 23 mutation identified by exome sequencing.

Shah A, Miller CJ, Nast CC, Adams MD, Truitt B, Tayek JA, Tong L, Mehtani P, Monteon F, Sedor JR, Clinkenbeard EL, White K, Mehrotra R, LaPage J, Dickson P, Adler SG, Iyengar SK.

Nephrol Dial Transplant. 2014 Dec;29(12):2235-43. doi: 10.1093/ndt/gfu324. Epub 2014 Nov 5.


Ferric citrate controls phosphorus and delivers iron in patients on dialysis.

Lewis JB, Sika M, Koury MJ, Chuang P, Schulman G, Smith MT, Whittier FC, Linfert DR, Galphin CM, Athreya BP, Nossuli AK, Chang IJ, Blumenthal SS, Manley J, Zeig S, Kant KS, Olivero JJ, Greene T, Dwyer JP; Collaborative Study Group.

J Am Soc Nephrol. 2015 Feb;26(2):493-503. doi: 10.1681/ASN.2014020212. Epub 2014 Jul 24.


Serum magnesium, phosphorus, and calcium are associated with risk of incident heart failure: the Atherosclerosis Risk in Communities (ARIC) Study.

Lutsey PL, Alonso A, Michos ED, Loehr LR, Astor BC, Coresh J, Folsom AR.

Am J Clin Nutr. 2014 Sep;100(3):756-64. doi: 10.3945/ajcn.114.085167. Epub 2014 Jul 16.


Refeeding and metabolic syndromes: two sides of the same coin.

Obeid OA, Hachem DH, Ayoub JJ.

Nutr Diabetes. 2014 Jun 30;4:e120. doi: 10.1038/nutd.2014.21.


Serum phosphorus and mortality in the Third National Health and Nutrition Examination Survey (NHANES III): effect modification by fasting.

Chang AR, Grams ME.

Am J Kidney Dis. 2014 Oct;64(4):567-73. doi: 10.1053/j.ajkd.2014.04.028. Epub 2014 Jun 14.


Fibroblast growth factor-23 and incident coronary heart disease, heart failure, and cardiovascular mortality: the Atherosclerosis Risk in Communities study.

Lutsey PL, Alonso A, Selvin E, Pankow JS, Michos ED, Agarwal SK, Loehr LR, Eckfeldt JH, Coresh J.

J Am Heart Assoc. 2014 Jun 10;3(3):e000936. doi: 10.1161/JAHA.114.000936.


Bone mineral metabolism and subsequent hospitalization with poor quality of life in dialysis patients.

Rostami Z, Hosseini MS, Lessan Pezeshki M, Heidari F, Einollahi B.

Nephrourol Mon. 2014 Jan 20;6(1):e14944. doi: 10.5812/numonthly.14944. eCollection 2014 Jan.


Assessing the health impact of phosphorus in the food supply: issues and considerations.

Calvo MS, Moshfegh AJ, Tucker KL.

Adv Nutr. 2014 Jan 1;5(1):104-13. doi: 10.3945/an.113.004861. Review.


The connection between dietary phosphorus, cardiovascular disease, and mortality: where we stand and what we need to know.

Gutiérrez OM.

Adv Nutr. 2013 Nov 6;4(6):723-9. doi: 10.3945/an.113.004812. eCollection 2013 Nov. Review.


Serum phosphate as a risk factor for cardiovascular events in people with and without chronic kidney disease: a large community based cohort study.

McGovern AP, de Lusignan S, van Vlymen J, Liyanage H, Tomson CR, Gallagher H, Rafiq M, Jones S.

PLoS One. 2013 Sep 10;8(9):e74996. doi: 10.1371/journal.pone.0074996. eCollection 2013.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk